One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback